Theron-Pharmaceuticals

License to

2018


Amunix

License to

Celgene

2018


Amunix

Sale of Royalties to

Bioverativ

2018


OncoTracker

License To

Juno

December 2017

Ovid

Sale to

Heat

2017

Ovid

Fairness Opinion

2017

Ovid

Global license

Gaboxadol from

Lundbeck

March 2015

Parnell

$50,000,000 Initial Public Offering / Co-Manager

June 2014

Agenus

Advisor

February 2014

Theron

Global License to

Galaxy BioTech

January 2013

Oxigene

$5 Million PIPE

Co-Placement Agent

April 2013

IGAN

Global Licensing of

IgA Protease

Shire

October 2012

Galaxy BioTech

Global Licensing of

HuGAL-F2

Roche

September 2012

Galaxy

Global Licensing of

HuGAL-FR21

Five Prime

December 2011

Altea Therapeutics

Advisor
2010-2011

Threshold Pharmaceuticals

Advisor
2009-2011

Bellus Health

Global license to

Celtic Pharma

May 2010

Inhibitex

Advisor
2010

Emergent Biosolutions

Advisor
2010

Threshold Pharmaceuticals

$35 Million PIPE

Lead Placement Agent

October 2009

Facet Biotech

Advisor
2009

Adventrix Pharmaceuticals

Advisor
2009

Bradmer Pharmaceuticals

Advisor
2008-2009

Navitas

Sale to

Gilead

May 2008

Geller Biopharm

  Broker / Dealer services provided by Pickwick Capital Partners, LLC. Member FINRA / SIPC